Tianjin Tianyao Pharmaceuticals (600488.SH): Injectable Methylprednisolone Sodium Succinate Obtains Registration Certificate from Panama Ministry of Health
Tianjin Pharmaceutical Industry (600488.SH) announcement, the company's subsidiary Tianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co., Ltd. (referred to as "...
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, JinYao Heping (Tianjin) Pharmaceutical Co., Ltd. (JinYao Heping), has obtained the registration certificate from the Ministry of Health of the Republic of Panama for the injection of methylprednisolone sodium succinate (signifying that the product can be produced and sold in the market of the Republic of Panama). Methylprednisolone sodium succinate injection is a type of glucocorticoid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood disorders and tumors, and treatment of shock, among other uses.
Related Articles
GREENTOWN SER (02869) spent HKD 945,800 to buy back 200,000 shares on November 18th.
On November 17th, STANCHART(02888) spent approximately 7.5339 million to repurchase approximately 471,200 shares.
On November 18, HAOHAI BIOTEC (06826) spent 4.8881 million Hong Kong dollars to repurchase 177,700 shares.
GREENTOWN SER (02869) spent HKD 945,800 to buy back 200,000 shares on November 18th.
On November 17th, STANCHART(02888) spent approximately 7.5339 million to repurchase approximately 471,200 shares.
On November 18, HAOHAI BIOTEC (06826) spent 4.8881 million Hong Kong dollars to repurchase 177,700 shares.
RECOMMEND
U.S. equities face “key defense lines,” testing bullish conviction; a break would confirm a downtrend into “early next year”
17/11/2025
Year-to-date Hong Kong share buybacks surpass HK$140 billion, with technology and financials leading activity
17/11/2025
Bitcoin’s year-to-date 30% rally “fully erased,” market slips into a bear phase
17/11/2025
